was established that includes software tools and a public repository for raw data (e.g. images), for annotations such as array maps that describe in textual matter the location, size and name of each DNA/RNA spot and for quantification output files (e.g. proscan) (Brazma et al., 2000) . For glycan microarray data many of these software tools are missing or still under construction and no glycan microarray repository has been created. In addition, the validation of glycan structure assignments by both readers and journals' reviewers is impeded by commonly used reporting procedures which do not provide the comprehensive description of relevant experimental parameters, computational methods and underlying assumptions. This in turn makes the successful annotation of data from the literature, as well as mining in databases, an uncertain endeavour and furthermore hampers interpretation and reproduction of this data.
The Beilstein Glyco-Bioinformatics Symposia have brought together glycochemists and biologists with experts in bioinformatics and computer science. The symposia have now become established as the platform to discuss the role of bioinformatics in glycomics. The launching of a new project called MIRAGE (Minimum Information Required for a Glycomics Experiment) and the foundation of the MIRAGE Commission under the auspices of the Beilstein-Institut was an important step to bring about essential agreements in standards for glycomics (York et al., 2014) . This group of internationally renowned scientists, with the involvement of the scientific community, is developing publication guidelines for the reporting of glycomics data, as well as data exchange formats, with the aim of setting up a framework to integrate glyco-bioinformatics in a comprehensive platform that will serve biologists, chemists and all interested in glycosciences. In detail, the Commission has developed and published guidelines for reporting the procedure of sample preparations (doi:10.3762/mirage.1) (Struwe et al., 2016) that are designed to include all aspects of sample generation, purification and modification from biological and/or synthetic material. These guidelines provide a basis for further MIRAGE guidelines such as reporting guidelines for mass spectrometry analysis data (doi:10.3762/mirage.2) (Kolarich et al., 2013) . These so-called MS Guidelines are based on the MIAPE guidelines (Minimum Information about a Proteomics Experiment) (Taylor et al., 2007) and aim at facilitating the collection and sharing comprehensive metadata that describe instrumentation, instrument setup and data acquisition protocols. The MIRAGE MS Guidelines were evaluated by representatives of several journals among them Glycobiology and Molecular and Cellular Proteomics (MCP) at a workshop in Athens, Georgia, in August 2012. At this workshop guidelines for reporting glycomics data based on mass spectrometry analysis were established, later called ''Athens Guidelines'' (Wells and Hart, 2013) . However, as the MIRAGE MS Guidelines are significantly more detailed than the Athens guidelines they are not currently strictly enforced by the editors of MCP or Glycobiology but implemented as a simplified check list for authors and reviewers. This checklist asks if specific information is available rather than asking for the information itself.
The most recent work of the Commission was the development of reporting guidelines for glycan microarray data (doi:10.3762/mirage.3) which will be published in due course. The purpose of these guidelines is to identify and highlight those essential parameters that should be reported when glycan microarrays are produced and analysed to make the published data interpretable for reviewers and readers.
An issue for which the symposia and the MIRAGE Commission laid the foundations, but without being directly involved in the outcome, was the agreement of a group of journals' editors on an updated monosaccharide symbol nomenclature for depicting glycans (Varki et al., 2015) . This nomenclature combines a number of different approaches to graphically represent glycans and hopefully will resolve difficulties with limitations and inconsistencies of previous symbol nomenclatures.
This symposium brought together scientists that ''produce'' the data with those scientists that ''use'' the data and make it available to the community. We would like to thank the authors, speakers and participants of this symposium who contributed in presentations and discussions to unravel the complexity of glycans and delivered insights into the diverse physiological and structural manifestations of sugars by covering aspects such as: carbohydrates in diagnosis and therapy, bridging the gap between analysis and storage of glycan data, structure-function relationships of carbohydrates, carbohydrate-protein interaction and glycoarrays and software tools for analysis and data mining.
